END individuals among all patients, as opposed to the other remainders, were substantially older, had experienced higher chances of previous antiplatelet use, dysphasia, vomiting, and intraventricular extension of hematoma, and possessed markedly elevated NIHSS scores, hematoma volumes, blood glucose levels and admission ATF3 levels (all p < 0.05; Table 5). The gene discussed is ATF3; the disease is hematoma.